Copyright © 1999 by the European Society of Cardiology.
Identification of a genetic risk factor for idiopathic dilated cardiomyopathy. Involvement of a polymorphism in the endothelin receptor type A gene
a Centre de Recherche de l'Association Claude Bernard and Université Paris VI (UPRES EA no 2390)
b Service de Cardiologie
m Service de Chirurgie Cardiaque
o INSERM U153, Hôpital Pitié-Salpêtrière, Paris
c INSERM SC7, Hôpital Broussais, Paris
d INSERM U258, Hôpital Broussais, Paris
e MONICA project-France
n INSERM U249, Montpellier, Services de Cardiologie and/or Chirurgie Cardiaque
f Hôpital Ambroise Paré, Boulogne
g Hôpital Laennec, Nantes
h Hôpital Cardiologique, Lille
i Hôpitaux de Brabois, Nancy
j Hôpital Haute-Pierre, Strasbourg
k Hôpital Louis Pradel, Lyon
l Hôpital Henri Mondor, Creteil
p Hôpital Boucicaut, Paris, France
revised May 7, 1999; accepted May 12, 1999
Abstract
Background Idiopathic dilated cardiomyopathy is a frequent cause of heart failure, a major concern of public health. Although idiopathic dilated cardiomyopathy may be familial, most cases are sporadic and the disease is considered to be multifactorial, for which genetic factors may account for a significant part.
Methods and Results We hypothesized that genetic abnormalities of the endothelin pathway may be involved in idiopathic dilated cardiomyopathy pathophysiology and therefore examined the possible association between idiopathic dilated cardiomyopathy and polymorphisms in genes encoding endothelin 1, endothelin type A and type B receptors, in a case-control study (433 patients and 400 age- and sex-matched control subjects). Analysis of the Exon 8 C/T polymorphism in the endothelin receptor type A gene indicated that individuals who are homozygote for the T allele were at significantly increased risk for the disease (odds ratio: 1·9; 95% confidence interval: 1·2 to 3·01;P<0·006). Analysis of the other polymorphisms indicated that no significant difference was observed in genotype or allele frequencies between cases and controls.
Conclusions The variant in the Exon 8 of the endothelin receptor type A gene appears as a genetic risk factor for idiopathic forms of heart failure. These results provide a new approach to the pathophysiology of idiopathic dilated cardiomyopathy.
Key Words: Gene, polymorphism, heart failure, cardiomyopathy, endothelin
f1 Correspondence: Michel Komajda, MD, Centre de Recherche de l'Association Claude Bernard, Pavillon Rambuteau, Hôpital Pitié-Salpêtrière, 47 Boulevard de l'Hôpital, 75651 Paris cedex 13, France.
References
- Braunwald E. Cardiovascular medecine at the turn of the millenium: triumphs, concerns, and opportunities. N Engl J Med. 1997;337:13601369
[Free Full Text] - Abraham WT, Bristow MR. Specialized centers for heart failure management. Circulation. 1997;96:27552757
[Free Full Text] - Circulation. 1996;93:841842
[Free Full Text] - Dec GM, Fuster V. Idiopathic dilated cardiomyopathy. N Engl J Med. 1994;331:15641575
[Free Full Text] - Kasper EK, Agema WRP, Hutchins GM, Deckers JW, Hare JM, Baughman KL. The cause of dilated cardiomyopathy: a clinicopathologic review of 673 consecutive patients. J Am Coll Cardiol. 1994;23:586590[Abstract]
- Manolio TA, Baughman KL, Rodeheffer R. Prevalence and etiology of idiopathic dilated cardiomyopathy. Am J Cardiol. 1992;69:14581466[CrossRef][Web of Science][Medline]
- Michels VV, Moll PP, Miller FA. The frequency of familial dilated cardiomyopathy in a series of patients with idiopathic dilated cardiomyopathy. N Engl J Med. 1992;326:7782[Abstract]
- Keeling PJ, Gang Y, Smith G. Familial dilated cardiomyopathy in the United Kingdom. Br Heart J. 1995;73:417421
[Abstract/Free Full Text] - Tunstall-Pedoe H, Kuulasmaa K, Amouyel P, Arveiler D, Rajakangas AM, Pajak A. Myocardial infarction and coronary deaths in the World Health Organization MONICA project. Registration procedures, event rates and case fatality in 38 populations from 21 countries in 4 continents. Circulation. 1994;90:583612
[Abstract/Free Full Text] - Nicaud V, Poirier O, Behague I. Polymorphisms of the endothelin-A and -B receptor genes in relation to blood pressure and myocardial infarction: the ECTIM Study. Am J Hypertens. 1999;12:304310[CrossRef][Web of Science][Medline]
- Colucci WS. Myocardial endothelin, does it play a role in myocardial failure? Circulation. 1996;93:10691072
[Free Full Text] - Schiffrin EL, Integan HD, Thibault G, Touyz RM. Clinical significance of endothelin in cardiovascular disease. Curr Opin Cardiol. 1997;12:354367[Web of Science][Medline]
- Sakai S, Miyauchi T, Sakurai T. Endogenous endothelin-1 participates in the maintenance of cardiac function in rats with congestive heart failure. Circulation. 1996;93:12141222
[Abstract/Free Full Text] - Pönicke K, Vogelsang M, Heinroth M. Endothelin receptors in the failing and nonfailing human heart. Circulation. 1998;97:744751
[Abstract/Free Full Text] - Sakai S, Miyauchi T, Kobayashi M, Yamaguchi I, Goto K, Sugishita Y. Inhibition of myocardial pathway improves long term survival in heart failure. Nature. 1996;384:353355[CrossRef][Medline]
- Fraccarollo D, Hu K, Galuppo P, Gaudron P, Ertl G. Chronic endothelin receptor blockade attenuates progressive ventricular dilation and improves cardiac function in rats with myocardial infarction. Circulation. 1997;96:39633973
[Abstract/Free Full Text] - Poort SR, Rosendaal FR, Reitsma PH, Bertina RM. A common genetic variant in the 3'-untranslated region of the thrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood. 1996;88:36983703
[Abstract/Free Full Text] - Raynolds MV, Bristow MR, Bush EW. Angiotensin-converting enzyme DD genotype in patients with ischemic or idiopathic dilated cardiomyopathy. Lancet. 1993;342:10731075[CrossRef][Web of Science][Medline]
- Montgomery HE, Keeling PJ, Goldman JH, Humphries SE, Talmud PJ, McKenna WJ. Lack of association between the insertion/deletion polymorphism of the angiotensin-converting enzyme gene and idiopathic dilated cardiomyopathy. J Am Coll Cardiol. 1993;25:16271631
- Sanderson JE, Young RP, Yu CM, Chan S, Critchley JA, Woo KS. Lack of association between insertion/deletion polymorphism of the angiotensin-converting enzyme gene and end-stage heart failure due to ischemic or idiopathic dilated cardiomyopathy in the chinese. Am J Cardiol. 1996;77:10081010[CrossRef][Web of Science][Medline]
- Yamada Y, Ichihara S, Fujimura T, Yokota M. Lack of association of polymorphism of the angiotensin-converting enzyme and angiotensinogen genes with non familial hypertrophic or dilated cardiomyopathy. Am J Hypertens. 1997;10:921928[CrossRef][Web of Science][Medline]
- Ichihara S, Yamada Y, Yokota M. Association of a G994T missense mutation in the plasma platelet-activating factor acethylhydrolase gene with genetic susceptibility to non familial dilated cardiomyopathy in Japanese. Circulation. 1998;98:18811885
[Abstract/Free Full Text] - Kubota T, McNamara DM, Wang JJ. Effects of tumor necrosis factor gene polymorphisms on patients with congestive heart failure. Circulation. 1998;97:24992501
[Abstract/Free Full Text] - Tesson F, Charron P, Peuchmaurd M. Characterization of a unique genetic variant in the beta 1-adrenoceptor gene and evaluation of its role in idiopathic dilated cardiomyopathy. J Mol Cell Cardiol. 1999;31:10251032[CrossRef][Web of Science][Medline]
This article has been cited by other articles:
![]() |
L. Duboscq-Bidot, P. Xu, P. Charron, N. Neyroud, G. Dilanian, A. Millaire, V. Bors, M. Komajda, and E. Villard Mutations in the Z-band protein myopalladin gene and idiopathic dilated cardiomyopathy Cardiovasc Res, January 1, 2008; 77(1): 118 - 125. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Richard, E. Villard, P. Charron, and R. Isnard The Genetic Bases of Cardiomyopathies J. Am. Coll. Cardiol., October 27, 2006; 48(9_Suppl_A): A79 - A89. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Thomson, P. Kumarathasan, P. Goegan, R. A. Aubin, and R. Vincent Differential Regulation of the Lung Endothelin System by Urban Particulate Matter and Ozone Toxicol. Sci., November 1, 2005; 88(1): 103 - 113. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Cascorbi, M. Paul, and H. K. Kroemer Pharmacogenomics of heart failure - focus on drug disposition and action Cardiovasc Res, October 1, 2004; 64(1): 32 - 39. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Hjalmarson, M. Fu, and R. Mobini Who are the enemies? Inflammation and autoimmune mechanisms Eur. Heart J. Suppl., November 1, 2002; 4(suppl_G): G27 - G32. [Abstract] [PDF] |
||||
![]() |
W. Kiowski The endothelin-type-A receptor in dilated cardiomyopathy: another key player? Eur. Heart J., October 2, 2001; 22(20): 1849 - 1851. [PDF] |
||||
![]() |
S.-M. Herrmann, K. Schmidt-Petersen, J. Pfeifer, A. Perrot, N. Bit-Avragim, C. Eichhorn, R. Dietz, R. Kreutz, M. Paul, and K.J. Osterziel A polymorphism in the endothelin-A receptor gene predicts survival in patients with idiopathic dilated cardiomyopathy Eur. Heart J., October 2, 2001; 22(20): 1948 - 1953. [Abstract] [PDF] |
||||
![]() |
C. Tzourio, M. El Amrani, O. Poirier, V. Nicaud, M.-G. Bousser, and A. Alperovitch Association between migraine and endothelin type A receptor (ETA -231 A/G) gene polymorphism Neurology, May 22, 2001; 56(10): 1273 - 1277. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. E. Spieker, G. Noll, F. T. Ruschitzka, and T. F. Luscher Endothelin receptor antagonists in congestive heart failure: a new therapeutic principle for the future? J. Am. Coll. Cardiol., May 1, 2001; 37(6): 1493 - 1505. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||





